Engineering Complex Bioarchitectures To Biomimic Nature: A Step Closer To The Development Of Artificial Organs
Santa Clara Convention Center, CA, USA
Grand Ballroom C
14:40 - 15:00
Our cutting edge biofabrication process creates infinite possibilities in the manufacture of artificial tissues and organs. By engineering Macro & Nano architectures in a single process unit, we have opened the door to a whole new world of possibilities allowing us to mimic biological systems identical to those found in nature.
Marc Thurner is CEO and founder of regenHU Ltd. Active in the advancement of biofabrication for over 15 years he is a leading contributor to the 3D bioprinting and tissue engineering scene
regenHU — a three dimensional biotechnology company, exploiting the potential of 3D bioprinting & cell based therapies — is a creative innovator in the development of biomedical products for regenerative medicine & drug discovery. Based in Fribourg, Switzerland, regenHU is a pioneer and global leader in its field, converging digital manufacturing (3D printing), biomaterials and biotechnology to create transformational innovations in Healthcare